Jennifer Robinson
Contatto Relazioni con gli Investitori presso VERVE THERAPEUTICS, INC.
Posizioni attive di Jennifer Robinson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VERVE THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - |
Storia della carriera di Jennifer Robinson
Precedenti posizioni note di Jennifer Robinson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DYAX CORP. | Contatto Relazioni con gli Investitori | 01/10/2011 | 01/04/2016 |
| Public Communications Contact | 01/10/2011 | 01/04/2016 | |
| RA PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - | |
| DECIPHERA PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - | |
| ADICET BIO, INC. | Contatto Relazioni con gli Investitori | 01/06/2018 | - |
| Public Communications Contact | 01/06/2018 | - |
Formazione di Jennifer Robinson
| Dartmouth College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Investor Relations Contact | 5 |
| Public Communications Contact | 5 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| VERVE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Robinson
- Esperienza
